Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1134626

registered interest
date	25/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what data his Department holds on Government expenditure on mental health provision for children and young people (a) under the age of 18; (b) from 18 to 25 years old in 2018-19.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	269148
answer	answer is ministerial correction date of answer 03/07/2019 answer text <p>Information on spend on mental health provision for children and young people aged 0-25, by clinical commissioning group (CCG), is published by NHS England in the Mental Health Five Year Forward View Dashboard.</p><p>NHS England also publishes spend on specialised commissioning on mental health provision for children and young people.</p><p>For 2018/19, the latest figures show planned expenditure by CCGs of £727 million and for specialised commissioning planned expenditure of £376 million.</p><p>These figures do not distinguish between those aged under the age of 18 and those aged 18 years to 25 years old.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 03/07/2019 16:02:52 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4662 label Biography information for Ruth George

1064443

registered interest
date	20/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of children under the age of 16 have had a (a) fatal and (b) non-fatal drug overdose in each of the last 10 years.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	223968
answer	answer is ministerial correction date of answer 25/02/2019 answer text <p>The information in the format requested is not held centrally. The Office for National Statistics publishes an annual summary of all deaths related to drug poisoning (involving both legal and illegal drugs) and drug misuse (involving illegal drugs) in England and Wales. Data on deaths in those aged under 20 is grouped together. The reports are available at the following link:</p><p><a href="http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsrelatedtodrugpoisoninginenglandandwales/2017registrations" target="_blank">www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsrelatedtodrugpoisoninginenglandandwales/2017registrations</a></p><p>NHS Digital collects Hospital Episode Statistics regarding intentional self-poisoning that resulted in a hospital admission, however to provide this information for the last ten years would incur disproportionate costs.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 223972 question first answered 25/02/2019 17:33:35 answering member 4067 label Biography information for Steve Brine
tabling member	4662 label Biography information for Ruth George

1064447

registered interest
date	20/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of children under the age of 18 that have had a (a) fatal and (b) non-fatal drug overdose in each of the last 10 years.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	223972
answer	answer is ministerial correction date of answer 25/02/2019 answer text <p>The information in the format requested is not held centrally. The Office for National Statistics publishes an annual summary of all deaths related to drug poisoning (involving both legal and illegal drugs) and drug misuse (involving illegal drugs) in England and Wales. Data on deaths in those aged under 20 is grouped together. The reports are available at the following link:</p><p><a href="http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsrelatedtodrugpoisoninginenglandandwales/2017registrations" target="_blank">www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsrelatedtodrugpoisoninginenglandandwales/2017registrations</a></p><p>NHS Digital collects Hospital Episode Statistics regarding intentional self-poisoning that resulted in a hospital admission, however to provide this information for the last ten years would incur disproportionate costs.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 223968 question first answered 25/02/2019 17:33:35 answering member 4067 label Biography information for Steve Brine
tabling member	4662 label Biography information for Ruth George

1058873

registered interest
date	11/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of risk-stratified screening for breast cancer.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	219575
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>The United Kingdom National Screening Committee (UK NSC) has recently closed its three month public consultation on risk stratification to offer additional breast screening with ultrasound after a negative mammography in women with dense breasts.</p><p>The UK NSC will convene at the end of the month to review comments from this consultation and will advise accordingly. Minutes of the meeting are usually published six weeks after its meeting and will be made available on the UK NSC website at the following link:</p><p><a href="https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc" target="_blank">https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 17:38:39 answering member 4067 label Biography information for Steve Brine
tabling member	4662 label Biography information for Ruth George

1058874

registered interest
date	11/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiology: Recruitment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the forthcoming NHS workforce implementation plan will include a plan to increase the numbers of NHS diagnostic radiographers.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	219576
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>My Rt. hon. Friend the Secretary of State for Health and Social Care has commissioned Baroness Dido Harding Chair of NHS Improvement, working closely with Sir David Behan, Chair of Health Education England, to lead a number of programmes to engage with key National Health Service interests to develop a detailed workforce implementation plan.</p><p> </p><p>This programme of work will consider detailed proposals to grow the workforce, including consideration of the additional staff and skills required to deliver round the clock high quality care. Baroness Harding and Sir David Behan will present initial recommendations to the Department in spring 2019. A final workforce implementation plan will follow later in the year, taking into account the outcomes of the Spending Review.</p><p> </p><p>Universities consistently continue to recruit students onto undergraduate diagnostic radiography university courses in England, with acceptances onto courses increasing every year since 2014. The latest NHS Digital data shows that as at October 2018 there are 3,084 more full time equivalent diagnostic radiographers in the NHS than there were in May 2010.</p><p> </p><p>Diagnostic radiographer education and training and recruitment in Wales, Northern Ireland and Scotland is a matter for the devolved governments in each nation.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 17:46:54 answering member 4067 label Biography information for Steve Brine
tabling member	4662 label Biography information for Ruth George

1046081

registered interest
date	22/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps NHS England will take to encourage the uptake of innovative and cost-effective medicines as set out in the 2019 voluntary scheme for branded medicines pricing and access.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	211348
answer	answer is ministerial correction date of answer 28/01/2019 answer text <p>The 2019 voluntary scheme for branded medicines pricing and access contains ambitions to improve patients’ outcomes and the health gain from medicines spend by simplifying, streamlining and improving access, pricing and uptake arrangements for cost-effective medicines; and delivering faster adoption of the most clinically and cost-effective medicines.</p><p>This will be supported by changes to the National Institute for Health and Care Excellence’s value assessment of new products, availability of increased commercial flexibility, and support for the National Health Service to increase uptake where appropriate. Use of products, particularly those which provide greatest health gain for patients, will be monitored and reviewed through this scheme. NHS England is developing a cohesive commercial framework to support this.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/01/2019 17:19:33 answering member 4067 label Biography information for Steve Brine
tabling member	4662 label Biography information for Ruth George

1043706

registered interest
date	18/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ocrelizumab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the status is of negotiations between Roche and NHS England on access to ocrelizumab for people with primary progressive MS on the NHS; and if he will take steps to help the two parties reach an agreement to deliver access to that drug.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	210045
answer	answer is ministerial correction date of answer 23/01/2019 answer text <p>In November 2018, my Rt. hon. Friend the Secretary of State for Health and Social Care, met with Roche to discuss life sciences, and briefly discussed the negotiations between Roche and NHS England on ocrelizumab. Similarly, the former Parliamentary Under-Secretary of State for Health (Lord O’Shaughnessy) met with Roche in December 2018. Both Ministers encouraged the on-going negotiations and agreed that these negotiations needed to continue in order to ensure the best conclusion for both parties, and patients that suffer from primary progressive multiple sclerosis. Those discussions are rightly for NHS England and Roche and it would not be appropriate for Ministers to intervene.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance on the use of ocrelizumab for the treatment of primary progressive multiple sclerosis. NHS England is in discussions with Roche, the manufacturer of ocrelizumab, to seek to agree a commercial agreement that might enable NICE to recommend use of the drug.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 210046 question first answered 23/01/2019 16:22:30 answering member 4067 label Biography information for Steve Brine
tabling member	4662 label Biography information for Ruth George

1043707

registered interest
date	18/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ocrelizumab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) Roche and (b) NHS England on introducing a managed access scheme for ocrelizumab to made available for people living with primary progressive MS.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	210046
answer	answer is ministerial correction date of answer 23/01/2019 answer text <p>In November 2018, my Rt. hon. Friend the Secretary of State for Health and Social Care, met with Roche to discuss life sciences, and briefly discussed the negotiations between Roche and NHS England on ocrelizumab. Similarly, the former Parliamentary Under-Secretary of State for Health (Lord O’Shaughnessy) met with Roche in December 2018. Both Ministers encouraged the on-going negotiations and agreed that these negotiations needed to continue in order to ensure the best conclusion for both parties, and patients that suffer from primary progressive multiple sclerosis. Those discussions are rightly for NHS England and Roche and it would not be appropriate for Ministers to intervene.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance on the use of ocrelizumab for the treatment of primary progressive multiple sclerosis. NHS England is in discussions with Roche, the manufacturer of ocrelizumab, to seek to agree a commercial agreement that might enable NICE to recommend use of the drug.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 210045 question first answered 23/01/2019 16:22:30 answering member 4067 label Biography information for Steve Brine
tabling member	4662 label Biography information for Ruth George

1035107

registered interest
date	04/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Social Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the Government’s preparations for the UK leaving the EU potentially with no deal are expected to delay the publication of the Social Care Green Paper.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	205416
answer	answer is ministerial correction date of answer 09/01/2019 answer text <p>No, as an ageing society, we need to reach a longer-term sustainable settlement for social care. The Social Care Green Paper remains a priority and the Government has committed to publishing at the earliest opportunity.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 09/01/2019 12:30:38 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4662 label Biography information for Ruth George

1035108

registered interest
date	04/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Social Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps the Department is taking to ensure that the Social Care Green Paper is published at the earliest opportunity.
tabling member constituency	High Peak
tabling member printed	Ruth George
uin	205417
answer	answer is ministerial correction date of answer 09/01/2019 answer text <p>The Social Care Green Paper remains a priority for this Government. The Department is working hard to publish a Green Paper setting out proposals for reform at the earliest opportunity.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 09/01/2019 12:29:34 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4662 label Biography information for Ruth George